Neurologian yksikkö
Department of Neurology

Julkaisut 2002
Publications 2002

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Alafuzoff I, Soininen H. Neuropathology and ethiopathogenesis of Alzheimer´s disease.
2 Anttila T et al. Midlife income, occupation, APOE status, and dementia.
3 Arabadzisz D et al. Increased inter-spike intervals and fast after-hyperpolarization of action potentials in rat hippocampal pyramidal cells accompanied with altered calbindin immunoreactivity 10-12 months after global forebrain ischemia.
4 Autere JM et al. Molecular genetic analysis of the alpha-synuclein and the parkin gene in Parkinson´s disease in Finland.
5 Barbelivien A et al. Differentially altered cerebral metabolism in ischemic rats by alfa2-adrenoceptor blockade and its relation to improved limb-placing reactions.
6 Barnett HJM et al. The appropriate use of carotid endarterectomy.
7 Boccardi M et al. Clinical characteristics of frontotemporal patients with symmetric brain atrophy.
8 Boccardi M et al. Amygdaloid atrophy in frontotemporal dementia and Alzheimer´s disease.
9 Bond R et al. Clinical and radiographic risk factors for operative stroke and death in the European Carotid Surgery Trial.
10 Bond R et al. Variation in surgical and anaesthetic technique and associations with operative risk in the European Carotid Surgery Trial: Implications for trials of ancillary techniques.
11 Bots ML et al. The EUROSTROKE cohorts: a short description and data analytical approach.
12 Bots ML et al. Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe.
13 Bots ML et al. Level of fibrinogen and risk of fatal non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.
14 Bots ML et al. Left ventricular hyprtrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.
15 Bots ML et al. gamma-Glutamyltransferase and risk of stroke: the EUROSTROKE project.
16 Buerger K et al. Differential diagnosis of Alzheimer Disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
17 Castrén M et al. BDNF regulates the expression of fragile X mental retardation protein mRNA in the hippocampus.
18 Cunningham EJ et al. Long-term durability of carotid endarterectomy for symptomatic stenosis and risk factors for late postoperative stroke.
19 Du AT et al. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus.
20 Eloranta M-L et al. Multidrug resistance 3 gene mutation 1712delT and estrogen receptor alfa gene polymorphisms in Finnish women with obstetric cholestasis.
21 Elovaara I, Alafuzoff I. Infectious dementias.
22 Frisoni GB et al. Radial width of the temporal horn: a sensitive measure in Alzheimer disease.
23 Frisoni GB et al. Detection of grey matter loss in mild Alzheimer´s disease with voxel based morphometry.
24 Gates PC et al. Identifying patients with symptomatic carotid artery disease at high and low risk of severe myocardial infarction and cardiac death.
25 Heikkinen T et al. Effects of ovariectomy and estrogen treatment on learning and hippocampal neurotransmitters in mice.
26 Heiskanen J et al. Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia.
27 Helkala E-L et al. Usefulness of repeated presentation of Mini-Mental State Examination as a diagnostic procedure - a population-based study.
28 Hietanen M et al. Neuropsychological examination of memory.
29 Hiltunen N, Kälviäinen R. Vaikeat epilepsiat. Tutkimus vaikeita epilepsioita sairastavista sekä heidän hoito-, tuki- ja palvelutilanteestaan.
30 Hokkanen L et al. Dementian diagnosoinnista etenevän muistihäiriön varhaiseen tunnistamiseen -neuropsykologinen näkökulma.
31 Hänninen T et al. Prevalence of mild cognitive impairment: a population-based study in elderly subjects.
32 Ihalainen JA, Tanila H. In vivo regulation of dopamine and noradrenaline release by alfa2A-adrenoceptors in the mouse prefrontal cortex.
33 Iivonen S et al. Seladin-1 transcription is linked to neuronal degeneration in Alzheimer´s disease.
34 Ikonen S et al. Cholinergic system regulation of spatial representation by the hippocampus.
35 Jolkkonen E et al. Projections from the amygdaloid complex to the magnocellular cholinergic basal forebrain in rat.
36 Joyal CC et al. A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia.
37 Jutila L et al. Long term outcome of temporal lobe epilepsy surgery: analyses of 140 consecutive patients.
38 Jutila L et al. Neurobiology of epileptogenesis in the temporal lobe.
39 Kaarisalo MM et al. The risk of stroke following coronary revascularization - a population-based long-term follow-up study.
40 Kaarniranta K et al. Neuronal cells show regulatory differences in the hsp70 gene response.
41 Kadish I. Plasticity in the Entorhinal-Hippocampal Pathway.
42 Kadish I et al. Transgenic mice expressing the human presenilin 1 gene demonstrate enhanced hippocampal reorganization following entorhinal cortex lesions.
43 Kadish I, van Groen T. Low levels of estrogen significantly diminish axonal sprouting after entorhinal cortex lesions in the mouse.
44 Kaste M et al. Mitä uutta tulossa aivoinfarktin ehkäisyyn?
45 Kerokoski P et al. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
46 Kerokoski P et al. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
47 Kivipelto M. Vascular Risk Factors in Alzheimer´s Disease and Mild Cognitive Impairment.
48 Kivipelto M et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.
49 Kivipelto M et al. Vascular risk factors, ApoE epsilon4 allele, and gender and the risk of Alzheimer´s disease: perspectives on prevention.
50 Kivipelto M et al. Hypertension and hypercholesterolaemia as risk factors for Alzheimer´s disease: potential for pharmacological intervention.
51 Kivipelto M et al. Hypertension and white matter lesions of the brain.
52 Koistinaho M et al. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation.
53 Korhonen P. Gene Regulation in Neuronal Degeneration - Role of mSin3 and YYI Factors.
54 Korhonen S et al. Lack of association between C-850T polymorphism of the gene encoding tumor necrosis factor-alfa and polycystic ovary syndrome.
55 Korolainen MA et al. Proteomic analysis of protein in Alzheimer's disease brain .
56 Kuhmonen J et al. Diazepam does not reduce infarct size in rats subjected to transient occlusion of the middle cerebral artery when normothermia is maintained.
57 Kurl S et al. Plasma vitamin C modifies the association between hypertension and risk of stroke.
58 Kuusisto E et al. Early accumulation of p62 in neurofibrillary tangles in Alzheimer´s disease: possible role in tangle fomation.
59 Kälviäinen R. Temporal lobe resection in a patient with severe psychiatric problems.
60 Kälviäinen R, Salmenperä T. Do recurrent seizures cause neuronal damage? A series of studies with MRI volumetry in adults with partial epilepsy.
61 Laakso MP. Structural imaging in impairment and the dementias: an update.
62 Laakso MP et al. Prefrontal volumes in habitually violent subjects with antisocial personality disorder and type 2 alcoholism.
63 Laasanen J et al. Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with preeclampsia.
64 Laasanen J et al. Fibrinogen and factor VII promoter polymorphism in women with preeclampsia.
65 Laasanen J et al. Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia.
66 Langhorne P et al. What are the components of effective stroke unit care?
67 Liu L et al. Effects of fimbria-fornix lesion and amyloid pathology on spatial learning and memory in transgenic APP+PS1 mice.
68 Liu L et al. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
69 Liu L et al. Fimbria-fornix lesion does not affect APP levels and amyloid deposition in the hippocampus of APP+PS1 double transgenic mice.
70 Liu Y et al. Apolipoprotein E polymorphism and acute ischemic stroke : a diffusion - and perfusion weighted magnetic resonance imaging study.
71 Marutle A et al. Elevated levels of Abeeta1-40 and Abeeta1-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice.
72 Mehta PD, Pirttilä T. Biological markers of Alzheimer´s disease.
73 Miettinen RA et al. Estimation of the total number of cholinergic neurons containing estrogen receptor-alpha in the rat basal forebrain.
74 Moons KGM et al. Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?
75 Nordlinder M et al. Calcium/calmodulin dependent protein kinase II in Alzheimer´s disease.
76 Overmyer M. Gliosis in Relation to Alzheimer´s Hallmark Lesions in Aging and Alzheimer´s Disease. A postmodern immunohistochemical study.
77 Parviainen I et al. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit.
78 Peurala SH et al. Cutaneous electrical stimulation may enhance sensorimotor recovery in chronic stroke.
79 Pirskanen M et al. Interleukin 1 alpha gene polymorphism as a suscetibility factor in Alzheimer´s disease and its influence on the extend of histopathological hallmark lesions of Alzheimer´s sisease.
80 Pirttilä T. Taudin kulkua muunteleva hoito MS-taudissa.
81 Pirttilä T, Alafuzoff I. Neuroinflammation in neurodegeneration: lessons from Alzheimer´s disease.
82 Pirttilä T et al. Alzheimerin taudin lääkehoitovasteen arviointi ja lääkekorvauslausuntojen laatiminen.
83 Pitkänen A et al. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy.
84 Puoliväli J et al. Alpha2C-adrenoceptor mediated regulation of cortical EEG arousal.
85 Puoliväli J et al. Hippocampal Abeeta42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice.
86 Puurunen K, Sivenius J. Influence of enriched environment on spatial learning following cerebral insult.
87 Ropponen KM et al. Castleman's disease of the leptomeninges - immunohistochemical findings in 2 cases.
88 Saarela J et al. Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24.
89 Savolainen S et al. Five-year outcome of normal pressure hydrocephalus with or without a shunt: predictive valua of the clinical sings, neuropsychological evaluation and infusion test.
90 Sivenius J et al. Käden pakotettu käyttö - lupaava aivohalvauspotilaiden kuntoutusmuoto.
91 Sivenius J et al. Aivohalvauspotilaiden kuntoutusmahdollisuudet tulevaisuudessa.
92 Soininen H. Relevance of APOE genotype in diagnostics and therapy of Alzheimer´s disease.
93 Soininen H, Hänninen T. Muistihäiriö: normaalia ikääntymistä vai dementiaa.
94 Soininen H, Partanen J. EEG as a diagnostic tool in dementia.
95 Solovyan VT et al. The role of topoisomerase II in the excision of DNA loop domains during apoptosis.
96 Streifler JY et al. Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis.
97 Suomen Neurologinen Yhdistys ry. Multippeliskleroosin diagnostiikka ja lääkehoito. Käypä hoito-suositus.
98 Tarkka IM et al. Auditory adaptation is differentially impaired in familial and sporadic Alzheimer`s disease.
99 Tolonen H et al. Do trends in population levels of blood pressure and other cardiovascular risk factors explain trends in stroke events rates? Comparisons of 15 populations in 9 countries within the WHO MONICA stroke project.
100 van Groen T et al. The role of the laterodorsal nucleus of the thalamus in spatial learning and memory in the rat.
101 van Groen T et al. Old rats remember old tricks; memories of the water maze persist for 12 months.
102 van Groen T et al. Species differences in the projections from the entorhinal cortex to the hippocampus.
103 van Groen T et al. Role of the anterodorsal and anteroventral nuclei of the thalamus in spatial memory in the rat.
104 Wang J et al. Alteration of cortical EEG in mice carrying mutated human APP transgene.
105 Wegiel J et al. Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome.
106 Äikiä M. Verbal Memory in Newly Diagnosed Partial Epilepsy. A neuropsychological study.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008